Literature DB >> 17141838

Incidence of primary urethral carcinoma in the United States.

Mia A Swartz1, Michael P Porter, Daniel W Lin, Noel S Weiss.   

Abstract

OBJECTIVES: Primary urethral carcinoma is rare, and the demographic correlates of its incidence have not been examined using population-based data.
METHODS: The National Cancer Institute Surveillance, Epidemiology, and End Results database was used to identify persons diagnosed with primary urethral carcinoma from 1973 to 2002. During this period, the Surveillance, Epidemiology, and End Results program included population-based tumor registries in nine geographic areas that represented approximately 10% of the U.S. population. The incidence rates were tabulated for the major histologic subtypes according to age, sex, and race.
RESULTS: Primary urethral carcinoma was identified in 1075 men and 540 women, with an annual age-adjusted incidence rate of 4.3 per million and 1.5 per million, respectively. The annual incidence rate increased with age to a peak of 32 per million men and 9.5 per million women in the 75 to 84-year age group. The rate was 5.0 per million and 2.5 per million for African Americans and whites, respectively. The histologic types were transitional cell carcinoma in 888 patients (55%), squamous cell carcinoma in 348 (21.5%), and adenocarcinoma in 265 (16.4%). The incidence of the three primary histologic types varied by race and sex.
CONCLUSIONS: In the United States, the incidence of urethral carcinoma is relatively higher in men and African Americans, with a histologic profile differing from that previously described.

Entities:  

Mesh:

Year:  2006        PMID: 17141838     DOI: 10.1016/j.urology.2006.08.1057

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  50 in total

1.  Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists.

Authors:  Farshid Dayyani; Curtis A Pettaway; Ashish M Kamat; Mark F Munsell; Kanishka Sircar; Lance C Pagliaro
Journal:  Urol Oncol       Date:  2012-04-24       Impact factor: 3.498

2.  A first reported case of clear cell carcinoma associated with delayed extrusion of midurethral tape.

Authors:  Harvard Zhenjia Lin; Fiona Meiwen Wu; Jeffrey Jen Hui Low; Kotamma Venkateswaran; Roy Kwok Weng Ng
Journal:  Int Urogynecol J       Date:  2015-11-20       Impact factor: 2.894

3.  Isolated urethral metastasis from appendiceal mucinous adenocarcinoma.

Authors:  Pamela I Causa Andrieu; Jennifer S Golia Pernicka; Gabriela Faria E Silva Costa; Gregory T Chesnut; Jaspreet S Shandu; Chen Ying-Bei; Iva Petkovska
Journal:  Clin Imaging       Date:  2020-05-30       Impact factor: 1.605

4.  The epidemiology and role of surgery in the treatment of urethral clear cell carcinoma.

Authors:  Mausam Patel; Jay Im; Austin Ivy; Sanjay Maraboyina; Thomas Kim
Journal:  Int Urol Nephrol       Date:  2019-09-25       Impact factor: 2.370

Review 5.  MRI of female urethra and periurethral pathologies.

Authors:  Malak Itani; Ania Kielar; Christine O Menias; Manjiri K Dighe; Venkat Surabhi; Srinivasa R Prasad; Ryan O'Malley; Kiran Gangadhar; Neeraj Lalwani
Journal:  Int Urogynecol J       Date:  2015-07-26       Impact factor: 2.894

Review 6.  MRI of common penile pathologies and penile prostheses.

Authors:  Abdul-Rahman Abualruz; Ryan O'Malley; Janardhana Ponnatapura; Brenda L Holbert; Pat Whitworth; Rafel Tappouni; Neeraj Lalwani
Journal:  Abdom Radiol (NY)       Date:  2020-09

7.  Urethral carcinoma: critical view on contemporary consecutive series.

Authors:  Leonardo Oliveira Reis; Fábio Ferreira; Murillo Almeida; Ubirajara Ferreira
Journal:  Med Oncol       Date:  2010-07-02       Impact factor: 3.064

8.  Primary Adenocarcinoma of the Bulbomembranous Urethra in a 33-Year-Old Male Patient.

Authors:  Rupesh Gupta; Sweta Gupta; Supriya Basu; Priyatosh Dey; Imran Ahmad Khan
Journal:  J Clin Diagn Res       Date:  2017-09-01

9.  [Organ and function preservation in urethral cancer].

Authors:  S Tritschler; K Lellig; A Roosen; A Horng; C Stief
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

Review 10.  Melanoma of the female urethra.

Authors:  Dino Papeš; Silvio Altarac
Journal:  Med Oncol       Date:  2012-12-18       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.